Market Place
Sourcing Support
Enforcement Report - Week of November 3, 2021
03 Nov 2021 //
FDA
US FDA accepts Axsome Therapeutics’ NDA filing for AXS-07 to treat migraine
16 Sep 2021 //
PHARMABIZ
Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-07
14 Sep 2021 //
GLOBENEWSWIRE
Axsome Therapeutics Presents New Data of AXS-07
24 Sep 2020 //
GLOBENEWSWIRE
Axsome celebrates migraine PhIII win, shifting eyes toward
06 Apr 2020 //
GLOBENESWIRE
Late-stage success for experimental migraine drug
02 Jan 2020 //
PHARMATIMES
Axsome Therapeutics
31 Dec 2019 //
GLOBENEWSWIRE
RedHill, IntelGenx receive Luxembourg regulatory marketing nod for Rizaport
15 Apr 2017 //
PHARMABIZ
Unichem Labs Generic Rizatriptan Benzoate Receives Approval In US
07 Mar 2017 //
FDA
Panacea biotec up 13 pact on US FDA nod for migraine drug
17 Jan 2017 //
ANINEWS
RedHill & IntelGenx Announce Agreement with Pharmatronic
14 Dec 2016 //
GLOBENEWSWIRE
USPTO Granted Patent Protecting IntelGenx`s Rizaport oral film for migraines
18 Feb 2016 //
CPHI ONLINE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.